Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1988 1
1989 1
1994 1
1996 4
1997 2
1998 1
1999 2
2000 1
2001 2
2002 2
2003 2
2004 6
2005 1
2006 2
2007 2
2008 3
2009 4
2010 6
2011 8
2012 8
2013 4
2014 7
2015 5
2016 7
2017 4
2018 2
2019 3
2020 6
2021 3
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study.
Loscertales J, Abrisqueta-Costa P, Gutierrez A, Hernández-Rivas JÁ, Andreu-Lapiedra R, Mora A, Leiva-Farré C, López-Roda MD, Callejo-Mellén Á, Álvarez-García E, García-Marco JA. Loscertales J, et al. Cancers (Basel). 2023 Aug 10;15(16):4047. doi: 10.3390/cancers15164047. Cancers (Basel). 2023. PMID: 37627075 Free PMC article.
[Pericardial window by videothorascopy].
Triviño A, Cózar F, Congregado M, Gallardo G, Moreno-Merino S, Jiménez-Merchán R, Loscertales J. Triviño A, et al. Among authors: loscertales j. Cir Esp. 2011 Dec;89(10):677-80. doi: 10.1016/j.ciresp.2011.05.006. Epub 2011 Sep 9. Cir Esp. 2011. PMID: 21906729 Spanish.
Pulmonary vein myxoid leiomyosarcoma.
González-Cámpora R, Rubi-Uria J, Mora-Marin J, Hevia A, Galera-Davidson H, Loscertales J, Ayarra J. González-Cámpora R, et al. Among authors: loscertales j. Pathol Res Pract. 1989 Dec;185(6):900-4; discussion 904-6. doi: 10.1016/S0344-0338(89)80293-6. Pathol Res Pract. 1989. PMID: 2616373
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.
Cuesta-Mateos C, Fuentes P, Schrader A, Juárez-Sánchez R, Loscertales J, Mateu-Albero T, Vega-Piris L, Espartero-Santos M, Marcos-Jimenez A, Sánchez-López BA, Pérez-García Y, Jungherz D, Oberbeck S, Wahnschaffe L, Kreutzman A, Andersson EI, Mustjoki S, Faber E, Urzainqui A, Fresno M, Stamatakis K, Alfranca A, Terrón F, Herling M, Toribio ML, Muñoz-Calleja C. Cuesta-Mateos C, et al. Among authors: loscertales j. Biomark Res. 2020 Oct 24;8:54. doi: 10.1186/s40364-020-00234-z. eCollection 2020. Biomark Res. 2020. PMID: 33110606 Free PMC article.
Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody.
Mateu-Albero T, Juárez-Sánchez R, Loscertales J, Mol W, Terrón F, Muñoz-Calleja C, Cuesta-Mateos C. Mateu-Albero T, et al. Among authors: loscertales j. Cancer Immunol Immunother. 2022 Mar;71(3):627-636. doi: 10.1007/s00262-021-03014-2. Epub 2021 Jul 23. Cancer Immunol Immunother. 2022. PMID: 34297159 Free PMC article.
87 results